Ucb Pharma, S.a.

Jonathan David MacDonald

Alan Findlay Haughan

Andrew Sharpe

Daniel Rees Allen

Elizabeth Anne Saville-Stones

Julien Alistair Brown

Roland W Bürli

Gilles Raphy

Mizio Matteucci

Andrew Pate Owens

David John Nash

Roland Burli

A series of substituted [1,3,5]triazin-2-yl derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.

Triazine derivatives as kinase inhibitors

A series of amino-substituted fused pyridine and pyrazine derivatives, in particular amino-substituted quinoline and quinoxaline derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.

Fused pyridine and pyrazine derivatives as kinase inhibitors

Growing community of inventors

Saffron Walden, United Kingdom

Jonathan David MacDonald